Abstract
ObjectivesTo determine the efficacy of enhanced recovery after surgery (ERAS) protocols in terms of frequency of surgical site infection (SSI) and length of hospital stay in patients undergoing colorectal surgeries for colorectal carcinoma.Study designQuasi-experimental study.Setting/Duration of studyDepartment of Surgery, Shifa International Hospital, Islamabad, from May 7, 2019 to November 6, 2019.MethodologyA total of 120 patients with colorectal carcinomas who fulfilled that sample selection criteria were studied. After randomization, patients were divided into two equal groups; one group received management under ERAS while the second group received conventional management. All patients were recorded for length of hospital stay and the development of SSIs. Data were analyzed using SPSS 26.0.ResultsThe mean age was 42.34 ± 14.45 years, with a male majority, i.e., 72 (60%). The mean duration of in-patient stay was 3.45 ± 1.73 days with ERAS and 8.25 ± 1.58 days with conventional management (p < 0.001). A total of 28 (23.3%) SSIs developed, of which nine (7.5%) SSIs occurred with ERAS, while 19 (15.8%) occurred with traditional management (p = 0.031).ConclusionERAS protocols have been demonstrated to be effective, cheap, and safe. There is a tangible reduction in length of hospital stay and incidence of SSIs which translates into reduced utilization of resources and financial costs. However, strict adherence to the protocol may be necessary to obtain the aforementioned benefits, which may be difficult to do in the face of professional, institutional, and personal inertia. Intensive efforts are required to make these protocols more convenient and attractive to implement, so as to facilitate conversion to this management approach.
Highlights
Colorectal cancer is the third leading cause of cancer mortality globally, accounting for 10.2% of all cancers, with an incidence of 1.85 million new cases per annum [1]
A total of 28 (23.3%) surgical site infection (SSI) developed, of which nine (7.5%) SSIs occurred with enhanced recovery after surgery (ERAS), while 19 (15.8%) occurred with traditional management (p = 0.031)
Evidence-based management is the cornerstone of modern healthcare therapeutics, and the treatment of colorectal cancer is no exception
Summary
Colorectal cancer is the third leading cause of cancer mortality globally, accounting for 10.2% of all cancers, with an incidence of 1.85 million new cases per annum [1]. Practices such as preoperative bowel preparation in colorectal surgery, routine use of nasogastric tubes, and nil by mouth instructions until bowel sounds are audible postoperatively are still widely practiced [4,5]. Factors such as pain, prolonged immobilization, and.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
